NPPA variant affects CV outcomes in hypertensive patients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1622, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TZDs linked to adverse CV outcomes in older DM patients

By  

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Statin therapy decreases cardiovascular (CV) morbidity and mortality to the same extent in hypertensive and nonhypertensive patients

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

CV outcomes similar with BP meds in metabolic syndrome

By  

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Antipsychotic dosage affects outcomes in schizophrenia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 438, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Amlodipine ± atorvastatin in hypertensive, obese patients

By  

Inpharma, Vol. 1, Iss. 1567, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite